{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:00:34Z","timestamp":1771862434439,"version":"3.50.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00228-025-03976-7","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:04:14Z","timestamp":1768802654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetic evaluation of doravirine and dolutegravir during paclitaxel-based chemotherapy: a case report in an HIV-positive woman with metastatic pancreatic cancer"],"prefix":"10.1007","volume":"82","author":[{"given":"Giacomo","family":"Pozza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Lisa","family":"Ridolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Matone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"della Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-6495","authenticated-orcid":false,"given":"Cristina","family":"Gervasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"6","key":"3976_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/17425255.2025.2489393","volume":"21","author":"D Cattaneo","year":"2025","unstructured":"Cattaneo D, Ridolfo AL, Dalu D, Pruneri C, Giacomelli A, Cossu MV, Ruggieri L, Fasola C, Civati A, Dolci A, La Verde N, Antinori S, Gori A, Gervasoni C (2025) Management of polypharmacy and potential drug-drug interactions in people with HIV and cancer: insights from a 4-year multidisciplinary clinic experience. Expert Opin Drug Metab Toxicol 21(6):729\u2013736. https:\/\/doi.org\/10.1080\/17425255.2025.2489393","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"3976_CR2","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1016\/j.jgo.2024.102158","volume":"16","author":"JY Islam","year":"2025","unstructured":"Islam JY, Zhou X, Baggett C, Jamjian C, Coghill A, Suneja G, Lund JL (2025) Potential drug-drug interactions between cancer therapies and active antiretroviral treatments among Medicare-enrolled patients with cancer and HIV. J Geriatr Oncol 16(2):102158. https:\/\/doi.org\/10.1016\/j.jgo.2024.102158","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"3976_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17425255.2024.2408004","volume":"21","author":"C Branch","year":"2025","unstructured":"Branch C, Parson-Martinez J, Cory TJ (2025) Drug-drug interactions in HIV-infected patients receiving chemotherapy. Expert Opin Drug Metab Toxicol 21(1):15\u201327. https:\/\/doi.org\/10.1080\/17425255.2024.2408004","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3976_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4939-3347-1","volume":"1395","author":"R Ghose","year":"2016","unstructured":"Ghose R, Mallick P, Taneja G, Chu C, Moorthy B (2016) In vitro approaches to study regulation of hepatic cytochrome P450 (CYP) 3A expression by Paclitaxel and rifampicin. Methods Mol Biol 1395:55\u201368. https:\/\/doi.org\/10.1007\/978-1-4939-3347-1","journal-title":"Methods Mol Biol"},{"issue":"3","key":"3976_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s1556-0864(15)31572-0","volume":"1","author":"G Asai","year":"2006","unstructured":"Asai G, Yamamoto N, Kurata T, Tamura K, Uejima H, Nakagawa K, Fukuoka M (2006) Phase I and Pharmacokinetic study of combination chemotherapy using Irinotecan and Paclitaxel in patients with lung cancer. J Thorac Oncol 1(3):226\u2013230. https:\/\/doi.org\/10.1016\/s1556-0864(15)31572-0","journal-title":"J Thorac Oncol"},{"issue":"4","key":"3976_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13318-023-00833-9","volume":"48","author":"S Bettonte","year":"2023","unstructured":"Bettonte S, Berton M, Stader F, Battegay M, Marzolini C (2023) Management of drug interactions with inducers: onset and disappearance of induction on cytochrome P450 3A4 and uridine diphosphate glucuronosyltransferase 1A1 substrates. Eur J Drug Metab Pharmacokinet 48(4):353\u2013362. https:\/\/doi.org\/10.1007\/s13318-023-00833-9","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03976-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03976-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03976-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:04:20Z","timestamp":1771859060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03976-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3976"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03976-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}